COVID-19 Impact on Global Thyroid Gland Disorders Treatment Market Size, Status and Forecast 2020-2026

September 2020 | 98 pages | ID: C9F0D9914069EN
QYResearch

Abstracts

This report focuses on the global Thyroid Gland Disorders Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Thyroid Gland Disorders Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• GlaxoSmithKline
• Pfizer, Inc
• Novartis International AG
• Abbott Laboratories
• AbbVie, Inc
• Sanofi
• Takeda Pharmaceutical
• Allergan Plc
• Merck KGaA
• Lannett Company, Inc
• Mylan N.V

Market segment by Type, the product can be split into

• Hypothyroidism
• Hyperthyroidism

Market segment by Application, split into

• Hospitals
• Clinics
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Thyroid Gland Disorders Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Thyroid Gland Disorders Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Thyroid Gland Disorders Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Thyroid Gland Disorders Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Thyroid Gland Disorders Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Hypothyroidism
  1.4.3 Hyperthyroidism
1.5 Market by Application
  1.5.1 Global Thyroid Gland Disorders Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Clinics
  1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Thyroid Gland Disorders Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Thyroid Gland Disorders Treatment Industry
    1.6.1.1 Thyroid Gland Disorders Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Thyroid Gland Disorders Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Thyroid Gland Disorders Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Thyroid Gland Disorders Treatment Market Perspective (2015-2026)
2.2 Thyroid Gland Disorders Treatment Growth Trends by Regions
  2.2.1 Thyroid Gland Disorders Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Thyroid Gland Disorders Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Thyroid Gland Disorders Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Thyroid Gland Disorders Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Thyroid Gland Disorders Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Thyroid Gland Disorders Treatment Players by Market Size
  3.1.1 Global Top Thyroid Gland Disorders Treatment Players by Revenue (2015-2020)
  3.1.2 Global Thyroid Gland Disorders Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Thyroid Gland Disorders Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Thyroid Gland Disorders Treatment Market Concentration Ratio
  3.2.1 Global Thyroid Gland Disorders Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Thyroid Gland Disorders Treatment Revenue in 2019
3.3 Thyroid Gland Disorders Treatment Key Players Head office and Area Served
3.4 Key Players Thyroid Gland Disorders Treatment Product Solution and Service
3.5 Date of Enter into Thyroid Gland Disorders Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Thyroid Gland Disorders Treatment Historic Market Size by Type (2015-2020)
4.2 Global Thyroid Gland Disorders Treatment Forecasted Market Size by Type (2021-2026)

5 THYROID GLAND DISORDERS TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Thyroid Gland Disorders Treatment Market Size by Application (2015-2020)
5.2 Global Thyroid Gland Disorders Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Thyroid Gland Disorders Treatment Market Size (2015-2020)
6.2 Thyroid Gland Disorders Treatment Key Players in North America (2019-2020)
6.3 North America Thyroid Gland Disorders Treatment Market Size by Type (2015-2020)
6.4 North America Thyroid Gland Disorders Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Thyroid Gland Disorders Treatment Market Size (2015-2020)
7.2 Thyroid Gland Disorders Treatment Key Players in Europe (2019-2020)
7.3 Europe Thyroid Gland Disorders Treatment Market Size by Type (2015-2020)
7.4 Europe Thyroid Gland Disorders Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Thyroid Gland Disorders Treatment Market Size (2015-2020)
8.2 Thyroid Gland Disorders Treatment Key Players in China (2019-2020)
8.3 China Thyroid Gland Disorders Treatment Market Size by Type (2015-2020)
8.4 China Thyroid Gland Disorders Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Thyroid Gland Disorders Treatment Market Size (2015-2020)
9.2 Thyroid Gland Disorders Treatment Key Players in Japan (2019-2020)
9.3 Japan Thyroid Gland Disorders Treatment Market Size by Type (2015-2020)
9.4 Japan Thyroid Gland Disorders Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Thyroid Gland Disorders Treatment Market Size (2015-2020)
10.2 Thyroid Gland Disorders Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Thyroid Gland Disorders Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Thyroid Gland Disorders Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Thyroid Gland Disorders Treatment Market Size (2015-2020)
11.2 Thyroid Gland Disorders Treatment Key Players in India (2019-2020)
11.3 India Thyroid Gland Disorders Treatment Market Size by Type (2015-2020)
11.4 India Thyroid Gland Disorders Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Thyroid Gland Disorders Treatment Market Size (2015-2020)
12.2 Thyroid Gland Disorders Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Thyroid Gland Disorders Treatment Market Size by Type (2015-2020)
12.4 Central & South America Thyroid Gland Disorders Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 GlaxoSmithKline
  13.1.1 GlaxoSmithKline Company Details
  13.1.2 GlaxoSmithKline Business Overview and Its Total Revenue
  13.1.3 GlaxoSmithKline Thyroid Gland Disorders Treatment Introduction
  13.1.4 GlaxoSmithKline Revenue in Thyroid Gland Disorders Treatment Business (2015-2020))
  13.1.5 GlaxoSmithKline Recent Development
13.2 Pfizer, Inc
  13.2.1 Pfizer, Inc Company Details
  13.2.2 Pfizer, Inc Business Overview and Its Total Revenue
  13.2.3 Pfizer, Inc Thyroid Gland Disorders Treatment Introduction
  13.2.4 Pfizer, Inc Revenue in Thyroid Gland Disorders Treatment Business (2015-2020)
  13.2.5 Pfizer, Inc Recent Development
13.3 Novartis International AG
  13.3.1 Novartis International AG Company Details
  13.3.2 Novartis International AG Business Overview and Its Total Revenue
  13.3.3 Novartis International AG Thyroid Gland Disorders Treatment Introduction
  13.3.4 Novartis International AG Revenue in Thyroid Gland Disorders Treatment Business (2015-2020)
  13.3.5 Novartis International AG Recent Development
13.4 Abbott Laboratories
  13.4.1 Abbott Laboratories Company Details
  13.4.2 Abbott Laboratories Business Overview and Its Total Revenue
  13.4.3 Abbott Laboratories Thyroid Gland Disorders Treatment Introduction
  13.4.4 Abbott Laboratories Revenue in Thyroid Gland Disorders Treatment Business (2015-2020)
  13.4.5 Abbott Laboratories Recent Development
13.5 AbbVie, Inc
  13.5.1 AbbVie, Inc Company Details
  13.5.2 AbbVie, Inc Business Overview and Its Total Revenue
  13.5.3 AbbVie, Inc Thyroid Gland Disorders Treatment Introduction
  13.5.4 AbbVie, Inc Revenue in Thyroid Gland Disorders Treatment Business (2015-2020)
  13.5.5 AbbVie, Inc Recent Development
13.6 Sanofi
  13.6.1 Sanofi Company Details
  13.6.2 Sanofi Business Overview and Its Total Revenue
  13.6.3 Sanofi Thyroid Gland Disorders Treatment Introduction
  13.6.4 Sanofi Revenue in Thyroid Gland Disorders Treatment Business (2015-2020)
  13.6.5 Sanofi Recent Development
13.7 Takeda Pharmaceutical
  13.7.1 Takeda Pharmaceutical Company Details
  13.7.2 Takeda Pharmaceutical Business Overview and Its Total Revenue
  13.7.3 Takeda Pharmaceutical Thyroid Gland Disorders Treatment Introduction
  13.7.4 Takeda Pharmaceutical Revenue in Thyroid Gland Disorders Treatment Business (2015-2020)
  13.7.5 Takeda Pharmaceutical Recent Development
13.8 Allergan Plc
  13.8.1 Allergan Plc Company Details
  13.8.2 Allergan Plc Business Overview and Its Total Revenue
  13.8.3 Allergan Plc Thyroid Gland Disorders Treatment Introduction
  13.8.4 Allergan Plc Revenue in Thyroid Gland Disorders Treatment Business (2015-2020)
  13.8.5 Allergan Plc Recent Development
13.9 Merck KGaA
  13.9.1 Merck KGaA Company Details
  13.9.2 Merck KGaA Business Overview and Its Total Revenue
  13.9.3 Merck KGaA Thyroid Gland Disorders Treatment Introduction
  13.9.4 Merck KGaA Revenue in Thyroid Gland Disorders Treatment Business (2015-2020)
  13.9.5 Merck KGaA Recent Development
13.10 Lannett Company, Inc
  13.10.1 Lannett Company, Inc Company Details
  13.10.2 Lannett Company, Inc Business Overview and Its Total Revenue
  13.10.3 Lannett Company, Inc Thyroid Gland Disorders Treatment Introduction
  13.10.4 Lannett Company, Inc Revenue in Thyroid Gland Disorders Treatment Business (2015-2020)
  13.10.5 Lannett Company, Inc Recent Development
13.11 Mylan N.V
  10.11.1 Mylan N.V Company Details
  10.11.2 Mylan N.V Business Overview and Its Total Revenue
  10.11.3 Mylan N.V Thyroid Gland Disorders Treatment Introduction
  10.11.4 Mylan N.V Revenue in Thyroid Gland Disorders Treatment Business (2015-2020)
  10.11.5 Mylan N.V Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Thyroid Gland Disorders Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Thyroid Gland Disorders Treatment Revenue
Table 3. Ranking of Global Top Thyroid Gland Disorders Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Thyroid Gland Disorders Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Hypothyroidism
Table 6. Key Players of Hyperthyroidism
Table 7. COVID-19 Impact Global Market: (Four Thyroid Gland Disorders Treatment Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Thyroid Gland Disorders Treatment Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Thyroid Gland Disorders Treatment Players to Combat Covid-19 Impact
Table 12. Global Thyroid Gland Disorders Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Thyroid Gland Disorders Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Thyroid Gland Disorders Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Thyroid Gland Disorders Treatment Market Share by Regions (2015-2020)
Table 16. Global Thyroid Gland Disorders Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Thyroid Gland Disorders Treatment Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Thyroid Gland Disorders Treatment Market Growth Strategy
Table 22. Main Points Interviewed from Key Thyroid Gland Disorders Treatment Players
Table 23. Global Thyroid Gland Disorders Treatment Revenue by Players (2015-2020) (Million US$)
Table 24. Global Thyroid Gland Disorders Treatment Market Share by Players (2015-2020)
Table 25. Global Top Thyroid Gland Disorders Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Thyroid Gland Disorders Treatment as of 2019)
Table 26. Global Thyroid Gland Disorders Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Thyroid Gland Disorders Treatment Product Solution and Service
Table 29. Date of Enter into Thyroid Gland Disorders Treatment Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Thyroid Gland Disorders Treatment Market Size by Type (2015-2020) (Million US$)
Table 32. Global Thyroid Gland Disorders Treatment Market Size Share by Type (2015-2020)
Table 33. Global Thyroid Gland Disorders Treatment Revenue Market Share by Type (2021-2026)
Table 34. Global Thyroid Gland Disorders Treatment Market Size Share by Application (2015-2020)
Table 35. Global Thyroid Gland Disorders Treatment Market Size by Application (2015-2020) (Million US$)
Table 36. Global Thyroid Gland Disorders Treatment Market Size Share by Application (2021-2026)
Table 37. North America Key Players Thyroid Gland Disorders Treatment Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Thyroid Gland Disorders Treatment Market Share (2019-2020)
Table 39. North America Thyroid Gland Disorders Treatment Market Size by Type (2015-2020) (Million US$)
Table 40. North America Thyroid Gland Disorders Treatment Market Share by Type (2015-2020)
Table 41. North America Thyroid Gland Disorders Treatment Market Size by Application (2015-2020) (Million US$)
Table 42. North America Thyroid Gland Disorders Treatment Market Share by Application (2015-2020)
Table 43. Europe Key Players Thyroid Gland Disorders Treatment Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Thyroid Gland Disorders Treatment Market Share (2019-2020)
Table 45. Europe Thyroid Gland Disorders Treatment Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Thyroid Gland Disorders Treatment Market Share by Type (2015-2020)
Table 47. Europe Thyroid Gland Disorders Treatment Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Thyroid Gland Disorders Treatment Market Share by Application (2015-2020)
Table 49. China Key Players Thyroid Gland Disorders Treatment Revenue (2019-2020) (Million US$)
Table 50. China Key Players Thyroid Gland Disorders Treatment Market Share (2019-2020)
Table 51. China Thyroid Gland Disorders Treatment Market Size by Type (2015-2020) (Million US$)
Table 52. China Thyroid Gland Disorders Treatment Market Share by Type (2015-2020)
Table 53. China Thyroid Gland Disorders Treatment Market Size by Application (2015-2020) (Million US$)
Table 54. China Thyroid Gland Disorders Treatment Market Share by Application (2015-2020)
Table 55. Japan Key Players Thyroid Gland Disorders Treatment Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Thyroid Gland Disorders Treatment Market Share (2019-2020)
Table 57. Japan Thyroid Gland Disorders Treatment Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Thyroid Gland Disorders Treatment Market Share by Type (2015-2020)
Table 59. Japan Thyroid Gland Disorders Treatment Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Thyroid Gland Disorders Treatment Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Thyroid Gland Disorders Treatment Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Thyroid Gland Disorders Treatment Market Share (2019-2020)
Table 63. Southeast Asia Thyroid Gland Disorders Treatment Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Thyroid Gland Disorders Treatment Market Share by Type (2015-2020)
Table 65. Southeast Asia Thyroid Gland Disorders Treatment Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Thyroid Gland Disorders Treatment Market Share by Application (2015-2020)
Table 67. India Key Players Thyroid Gland Disorders Treatment Revenue (2019-2020) (Million US$)
Table 68. India Key Players Thyroid Gland Disorders Treatment Market Share (2019-2020)
Table 69. India Thyroid Gland Disorders Treatment Market Size by Type (2015-2020) (Million US$)
Table 70. India Thyroid Gland Disorders Treatment Market Share by Type (2015-2020)
Table 71. India Thyroid Gland Disorders Treatment Market Size by Application (2015-2020) (Million US$)
Table 72. India Thyroid Gland Disorders Treatment Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Thyroid Gland Disorders Treatment Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Thyroid Gland Disorders Treatment Market Share (2019-2020)
Table 75. Central & South America Thyroid Gland Disorders Treatment Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Thyroid Gland Disorders Treatment Market Share by Type (2015-2020)
Table 77. Central & South America Thyroid Gland Disorders Treatment Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Thyroid Gland Disorders Treatment Market Share by Application (2015-2020)
Table 79. GlaxoSmithKline Company Details
Table 80. GlaxoSmithKline Business Overview
Table 81. GlaxoSmithKline Product
Table 82. GlaxoSmithKline Revenue in Thyroid Gland Disorders Treatment Business (2015-2020) (Million US$)
Table 83. GlaxoSmithKline Recent Development
Table 84. Pfizer, Inc Company Details
Table 85. Pfizer, Inc Business Overview
Table 86. Pfizer, Inc Product
Table 87. Pfizer, Inc Revenue in Thyroid Gland Disorders Treatment Business (2015-2020) (Million US$)
Table 88. Pfizer, Inc Recent Development
Table 89. Novartis International AG Company Details
Table 90. Novartis International AG Business Overview
Table 91. Novartis International AG Product
Table 92. Novartis International AG Revenue in Thyroid Gland Disorders Treatment Business (2015-2020) (Million US$)
Table 93. Novartis International AG Recent Development
Table 94. Abbott Laboratories Company Details
Table 95. Abbott Laboratories Business Overview
Table 96. Abbott Laboratories Product
Table 97. Abbott Laboratories Revenue in Thyroid Gland Disorders Treatment Business (2015-2020) (Million US$)
Table 98. Abbott Laboratories Recent Development
Table 99. AbbVie, Inc Company Details
Table 100. AbbVie, Inc Business Overview
Table 101. AbbVie, Inc Product
Table 102. AbbVie, Inc Revenue in Thyroid Gland Disorders Treatment Business (2015-2020) (Million US$)
Table 103. AbbVie, Inc Recent Development
Table 104. Sanofi Company Details
Table 105. Sanofi Business Overview
Table 106. Sanofi Product
Table 107. Sanofi Revenue in Thyroid Gland Disorders Treatment Business (2015-2020) (Million US$)
Table 108. Sanofi Recent Development
Table 109. Takeda Pharmaceutical Company Details
Table 110. Takeda Pharmaceutical Business Overview
Table 111. Takeda Pharmaceutical Product
Table 112. Takeda Pharmaceutical Revenue in Thyroid Gland Disorders Treatment Business (2015-2020) (Million US$)
Table 113. Takeda Pharmaceutical Recent Development
Table 114. Allergan Plc Business Overview
Table 115. Allergan Plc Product
Table 116. Allergan Plc Company Details
Table 117. Allergan Plc Revenue in Thyroid Gland Disorders Treatment Business (2015-2020) (Million US$)
Table 118. Allergan Plc Recent Development
Table 119. Merck KGaA Company Details
Table 120. Merck KGaA Business Overview
Table 121. Merck KGaA Product
Table 122. Merck KGaA Revenue in Thyroid Gland Disorders Treatment Business (2015-2020) (Million US$)
Table 123. Merck KGaA Recent Development
Table 124. Lannett Company, Inc Company Details
Table 125. Lannett Company, Inc Business Overview
Table 126. Lannett Company, Inc Product
Table 127. Lannett Company, Inc Revenue in Thyroid Gland Disorders Treatment Business (2015-2020) (Million US$)
Table 128. Lannett Company, Inc Recent Development
Table 129. Mylan N.V Company Details
Table 130. Mylan N.V Business Overview
Table 131. Mylan N.V Product
Table 132. Mylan N.V Revenue in Thyroid Gland Disorders Treatment Business (2015-2020) (Million US$)
Table 133. Mylan N.V Recent Development
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Thyroid Gland Disorders Treatment Market Share by Type: 2020 VS 2026
Figure 2. Hypothyroidism Features
Figure 3. Hyperthyroidism Features
Figure 4. Global Thyroid Gland Disorders Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Other Case Studies
Figure 8. Thyroid Gland Disorders Treatment Report Years Considered
Figure 9. Global Thyroid Gland Disorders Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Thyroid Gland Disorders Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Thyroid Gland Disorders Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Thyroid Gland Disorders Treatment Market Share by Players in 2019
Figure 14. Global Top Thyroid Gland Disorders Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Thyroid Gland Disorders Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Thyroid Gland Disorders Treatment Revenue in 2019
Figure 16. North America Thyroid Gland Disorders Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Thyroid Gland Disorders Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Thyroid Gland Disorders Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Thyroid Gland Disorders Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Thyroid Gland Disorders Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Thyroid Gland Disorders Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Thyroid Gland Disorders Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. GlaxoSmithKline Revenue Growth Rate in Thyroid Gland Disorders Treatment Business (2015-2020)
Figure 25. Pfizer, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Pfizer, Inc Revenue Growth Rate in Thyroid Gland Disorders Treatment Business (2015-2020)
Figure 27. Novartis International AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Novartis International AG Revenue Growth Rate in Thyroid Gland Disorders Treatment Business (2015-2020)
Figure 29. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Abbott Laboratories Revenue Growth Rate in Thyroid Gland Disorders Treatment Business (2015-2020)
Figure 31. AbbVie, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. AbbVie, Inc Revenue Growth Rate in Thyroid Gland Disorders Treatment Business (2015-2020)
Figure 33. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Sanofi Revenue Growth Rate in Thyroid Gland Disorders Treatment Business (2015-2020)
Figure 35. Takeda Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Takeda Pharmaceutical Revenue Growth Rate in Thyroid Gland Disorders Treatment Business (2015-2020)
Figure 37. Allergan Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Allergan Plc Revenue Growth Rate in Thyroid Gland Disorders Treatment Business (2015-2020)
Figure 39. Merck KGaA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Merck KGaA Revenue Growth Rate in Thyroid Gland Disorders Treatment Business (2015-2020)
Figure 41. Lannett Company, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Lannett Company, Inc Revenue Growth Rate in Thyroid Gland Disorders Treatment Business (2015-2020)
Figure 43. Mylan N.V Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Mylan N.V Revenue Growth Rate in Thyroid Gland Disorders Treatment Business (2015-2020)
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed